Table 4.
Summary of significant (multivariate adjusted ptrend<.05) associations between flavonoid intakes and various cardiovascular outcomes in prospective cohorts in US and European countries
Number of cohorts with significant associations/number of cohorts examined
| Mortality | Incidence | Number cohorts |
All publications |
|||||
|---|---|---|---|---|---|---|---|---|
| Flavonoid Class | CHD | Stroke | CVD | CHD | Stroke | CVD | ||
| Flavonols & flavones | 1a/6e | 0/1 | 0/1 | 0/6e | 1/4 | 0/1 | 1/8 | 3/11 |
| Flavonols | 2/5d | 0/1 | 0/2 | 0/5 | 2/3c | 0/1 | 3/9 | 3/10 |
| Flavones | 0/1a | 0/1 | 0/2 | 1/1 | 0/2 | 0/1 | 1/4 | 1/5 |
| Flavanones | 1/2 | 0/1 | 1/2 | 1/2 | 2/3 | 2/3 | ||
| Flavan-3-ols | 1/2b | 0/2 | 0/2 | 0/1 | 0/2 | 1/3 | 1/4 | |
| Anthocyanidins | 1/1 | 0/1 | 1/2 | 0/1 | 1/2 | 1/2 | ||
| Isoflavones | 0/1 | 0/1 | 0/1 | 0/1 | 0/1 | 0/1 | 0/2 | 0/2 |
| Proanthocyanidins | 0/1 | 0/1 | 0/1 | 0/1 | 0/1 | |||
| Number of cohorts studied | 4/8 | 0/2 | 1/3 | 1/9 | 3/7 | 0/2 | 6/12 | |
| All publications | 6/13 | 0/3 | 1/3 | 1/11 | 3/9 | 0/2 | 8/20 | |
a
two publications
b
three publications
c
four publications
d
six publications
e
seven publications